Inflammatory factor in the clinical picture and therapy of irritable bowel syndrome

Abstract

The article shows the dynamics of evaluation of prognostic factors of irritable bowel syndrome. Evolution of the views indicates an increasing evaluation of inflammation and the role of markers of inflammation of cytokines, especially alpha-TNF in clinical manifestations. The rationale for using a complex drug based on affinity purified release-active antibodies to alpha-TNF, to the brain-specific protein S-100 and histamine-colourant is presented.

Keywords

• irritable bowel syndrome
• rome iv criteria
• inducer of tnf-alpha
• bacterial lipopolysaccharides